Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 16,538 shares at $24.86 ($411K) on 2025-08-25, disclosed to the SEC on 2025-08-27.
Open-market sale of $411k NAMS by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.86 | 8,269 | $206K | 50.0% |
| 2 | $24.86 | 8,269 | $206K | 50.0% |
| Total | $24.86 avg | 16,538 | $411K | 100% |
| Filing → |
| NAMS | SELL | 2026-05-27 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-29 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-27 | $2.4M | — | Filing → |